Bridgewater H, Date K, ONeil J, Hu C, Arrand J, Dawson C
Pathogens. 2020; 9(7).
PMID: 32708289
PMC: 7400503.
DOI: 10.3390/pathogens9070594.
Totonchy J, Osborn J, Chadburn A, Nabiee R, Argueta L, Mikita G
PLoS Pathog. 2018; 14(4):e1006967.
PMID: 29659614
PMC: 5919685.
DOI: 10.1371/journal.ppat.1006967.
Niller H, Minarovits J
Pathogens. 2014; 1(1):37-51.
PMID: 25436603
PMC: 4235684.
DOI: 10.3390/pathogens1010037.
van den Bosch C
Adv Hematol. 2012; 2012:494758.
PMID: 22550493
PMC: 3328886.
DOI: 10.1155/2012/494758.
Valentine R, Dawson C, Hu C, Shah K, Owen T, Date K
Mol Cancer. 2010; 9:1.
PMID: 20051109
PMC: 2818691.
DOI: 10.1186/1476-4598-9-1.
Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.
Dreyfus D
PLoS One. 2009; 4(6):e5778.
PMID: 19492059
PMC: 2686171.
DOI: 10.1371/journal.pone.0005778.
Is the Epstein-Barr virus EBNA-1 protein an oncogen?.
Schulz T, Cordes S
Proc Natl Acad Sci U S A. 2009; 106(7):2091-2.
PMID: 19211802
PMC: 2650111.
DOI: 10.1073/pnas.0812575106.
Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.
Marr-Belvin A, Carville A, Fahey M, Boisvert K, Klumpp S, Ohashi M
Vet Pathol. 2008; 45(6):914-21.
PMID: 18984796
PMC: 2735115.
DOI: 10.1354/vp.45-6-914.
Mechanisms involved in Burkitt's tumor formation.
Campanero M
Clin Transl Oncol. 2008; 10(5):250-5.
PMID: 18490240
DOI: 10.1007/s12094-008-0193-x.
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.
Humme S, Reisbach G, Feederle R, Delecluse H, Bousset K, Hammerschmidt W
Proc Natl Acad Sci U S A. 2003; 100(19):10989-94.
PMID: 12947043
PMC: 196914.
DOI: 10.1073/pnas.1832776100.
Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.
Wu H, Kapoor P, Frappier L
J Virol. 2002; 76(5):2480-90.
PMID: 11836426
PMC: 135949.
DOI: 10.1128/jvi.76.5.2480-2490.2002.
Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth.
Kang M, Hung S, Kieff E
Proc Natl Acad Sci U S A. 2001; 98(26):15233-8.
PMID: 11734622
PMC: 65012.
DOI: 10.1073/pnas.211556598.
Epstein-Barr virus infection and human malignancies.
Niedobitek G, Meru N, Delecluse H
Int J Exp Pathol. 2001; 82(3):149-70.
PMID: 11488990
PMC: 2517709.
DOI: 10.1046/j.1365-2613.2001.iep0082-0149-x.
Biology and disease associations of Epstein-Barr virus.
Crawford D
Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):461-73.
PMID: 11313005
PMC: 1088438.
DOI: 10.1098/rstb.2000.0783.
Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
Ruf I, Sample J
J Virol. 1999; 73(10):7943-51.
PMID: 10482541
PMC: 112808.
DOI: 10.1128/JVI.73.10.7943-7951.1999.
Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.
Kube D, Vockerodt M, Weber O, Hell K, Wolf J, Haier B
J Virol. 1999; 73(2):1630-6.
PMID: 9882370
PMC: 103989.
DOI: 10.1128/JVI.73.2.1630-1636.1999.
Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes.
Huang S, Stupack D, Mathias P, Wang Y, Nemerow G
Proc Natl Acad Sci U S A. 1997; 94(15):8156-61.
PMID: 9223331
PMC: 21573.
DOI: 10.1073/pnas.94.15.8156.
Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.
Oudejans J, Dukers D, Jiwa N, van den Brule A, Grasser F, de Bruin P
J Clin Pathol. 1996; 49(11):897-902.
PMID: 8944608
PMC: 500828.
DOI: 10.1136/jcp.49.11.897.
c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
POLACK A, Hortnagel K, Pajic A, Christoph B, Baier B, Falk M
Proc Natl Acad Sci U S A. 1996; 93(19):10411-6.
PMID: 8816814
PMC: 38398.
DOI: 10.1073/pnas.93.19.10411.